QSS
RGNX icon

Quantitative Systematic Strategies’s Regenxbio RGNX Stock Holding History

Quantitative Systematic Strategies’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,540
Closed -$206K – 746
2020
Q4 		$206K Buy
+4,540
New +$159K 0.03% 560
2018
Q4 		– Sell
-2,696
Closed -$204K – 836
2018
Q3 		$204K Buy
+2,696
New +$194K 0.04% 524

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quantitative Systematic Strategies's RGNX Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 4,540 shares — an estimated $206K sold.

Quantitative Systematic Strategies first reported a position in RGNX in Q3 2018 and held it in 2 quarters. The position peaked at $206K in Q4 2020. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,540 Regenxbio shares in Q1 2021, an estimated $206K.
  • Quantitative Systematic Strategies first reported a position in Regenxbio in Q3 2018 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Regenxbio position peaked at $206K in Q4 2020.
  • 184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.